KPIs & Operating Metrics(New)
Growth Metrics

Hologic (HOLX) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Hologic (HOLX) over the last 17 years, with Q4 2025 value amounting to $170.9 million.

  • Hologic's Current Deferred Revenue fell 885.33% to $170.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $170.9 million, marking a year-over-year decrease of 885.33%. This contributed to the annual value of $199.7 million for FY2025, which is 620.01% down from last year.
  • Latest data reveals that Hologic reported Current Deferred Revenue of $170.9 million as of Q4 2025, which was down 885.33% from $199.7 million recorded in Q3 2025.
  • Over the past 5 years, Hologic's Current Deferred Revenue peaked at $232.9 million during Q3 2023, and registered a low of $170.9 million during Q4 2025.
  • In the last 5 years, Hologic's Current Deferred Revenue had a median value of $199.6 million in 2022 and averaged $203.1 million.
  • As far as peak fluctuations go, Hologic's Current Deferred Revenue surged by 2170.19% in 2021, and later plummeted by 976.14% in 2024.
  • Quarter analysis of 5 years shows Hologic's Current Deferred Revenue stood at $192.1 million in 2021, then dropped by 0.26% to $191.6 million in 2022, then decreased by 0.52% to $190.6 million in 2023, then fell by 1.63% to $187.5 million in 2024, then dropped by 8.85% to $170.9 million in 2025.
  • Its last three reported values are $170.9 million in Q4 2025, $199.7 million for Q3 2025, and $212.7 million during Q2 2025.